{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:39:57Z","timestamp":1790815197555,"version":"4.1.0"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi240973-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Schizophrenia is associated with premature mortality from mostly natural causes. Decreased cognitive functioning has been identified as a determinant of mortality in the general population. However, there have been few prospective studies of this issue in persons with schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240973-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine whether lower cognitive functioning is a risk factor for natural cause mortality in schizophrenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240973-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective cohort study included persons with schizophrenia or schizoaffective disorder enrolled between February 1, 1999, and December 31, 2022, at a nonprofit psychiatric system in Baltimore, Maryland. Participants were evaluated using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and other clinical measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240973-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Natural cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240973-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Associations of cognitive function, obesity, tobacco smoking, and medical conditions with natural cause mortality were evaluated using Cox proportional hazards regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240973-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 844 participants enrolled (mean [SD] age, 39.6 [12.1] years; 533 male [63.2%]), 158 (18.7%) died of natural causes during a median follow-up of 14.4 years (range, 7.0 days to 23.9 years). The most significant factor associated with mortality was lower cognitive functioning as measured by the RBANS (Cox coefficient, \u22120.04; 95% CI, \u22120.05 to \u22120.03;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u2009\u22125.72; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Additional factors independently associated with mortality included the diagnosis of an autoimmune disorder (hazard ratio [HR], 2.86; 95% CI, 1.83-4.47;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u20094.62; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), tobacco smoking (HR, 2.26; 95% CI, 1.55-3.30;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u20094.23; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), diagnosis of chronic obstructive pulmonary disease (HR, 3.31; 95% CI, 1.69-6.49;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u20093.48; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.006), body mass index as a continuous variable (HR, 1.06; 95% CI, 1.02-1.09;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u20093.30; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01), diagnosis of a cardiac rhythm disorder (HR, 2.56; 95% CI, 1.40-4.69;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u20093.06; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02), and being divorced or separated (HR, 1.80; 95% CI, 1.22-2.65;\n                      <jats:italic>z<\/jats:italic>\n                      \u2009=\u20092.97; adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02). An RBANS score below the 50th percentile displayed a joint association with being a smoker, having an elevated body mass index, and having a diagnosis of an autoimmune or a cardiac rhythm disorder.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi240973-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this prospective cohort study, lower cognitive functioning was a risk factor for natural cause mortality in schizophrenia. Efforts should be directed at methods to improve cognitive functioning, particularly among individuals with additional risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.32401","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:01:15Z","timestamp":1725966075000},"page":"e2432401","source":"Crossref","is-referenced-by-count":22,"title":["Risk Factors for Natural Cause Mortality in Schizophrenia"],"prefix":"10.1001","volume":"7","author":[{"given":"Faith","family":"Dickerson","sequence":"first","affiliation":[{"name":"Stanley Research Program, Sheppard Pratt, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahat","family":"Khan","sequence":"additional","affiliation":[{"name":"Stanley Research Program, Sheppard Pratt, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Origoni","sequence":"additional","affiliation":[{"name":"Stanley Research Program, Sheppard Pratt, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Rowe","sequence":"additional","affiliation":[{"name":"Stanley Research Program, Sheppard Pratt, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Katsafanas","sequence":"additional","affiliation":[{"name":"Stanley Research Program, Sheppard Pratt, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Harvin","sequence":"additional","affiliation":[{"name":"Stanley Research Program, Sheppard Pratt, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuojia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yolken","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"issue":"4","key":"zoi240973r1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis.","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"zoi240973r2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.","volume":"72","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi240973r3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.v21.2","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors.","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry"},{"issue":"10","key":"zoi240973r4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"zoi240973r5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1359786810384639","article-title":"Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?","volume":"24","author":"Wildgust","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"12","key":"zoi240973r6","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.3390\/healthcare10122366","article-title":"Mortality in schizophrenia-spectrum disorders: recent advances in understanding and management.","volume":"10","author":"Peritogiannis","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"zoi240973r7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.schres.2019.07.058","article-title":"Increased risk of smoking-related illnesses in schizophrenia patients: a nationwide cohort study.","volume":"212","author":"Krieger","year":"2019","journal-title":"Schizophr Res"},{"issue":"6","key":"zoi240973r8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.psyneuen.2012.09.009","article-title":"Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies.","volume":"38","author":"Harris","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"zoi240973r9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4088\/JCP.15m10271","article-title":"Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.","volume":"77","author":"Fontanella","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"zoi240973r10","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment.","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"9","key":"zoi240973r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105529","article-title":"Chronic kidney disease and cognitive impairment.","volume":"30","author":"Murtaza","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"zoi240973r12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1183\/09031936.00125109","article-title":"Cognitive function in COPD.","volume":"35","author":"Dodd","year":"2010","journal-title":"Eur Respir J"},{"issue":"11","key":"zoi240973r13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10654-018-0439-z","article-title":"Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality.","volume":"33","author":"Hayat","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"zoi240973r14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41562-021-01078-9","article-title":"Intelligence, health and death.","volume":"5","author":"Deary","year":"2021","journal-title":"Nat Hum Behav"},{"key":"zoi240973r15","doi-asserted-by":"publisher","first-page":"j2708","DOI":"10.1136\/bmj.j2708","article-title":"Childhood intelligence in relation to major causes of death in 68 year follow-up: prospective population study.","volume":"357","author":"Calvin","year":"2017","journal-title":"BMJ"},{"issue":"9596","key":"zoi240973r16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"zoi240973r19","doi-asserted-by":"publisher","journal-title":"Front Public Health","DOI":"10.3389\/fpubh.2015.00051"},{"key":"zoi240973r20","doi-asserted-by":"publisher","journal-title":"Trends Cardiovasc Med","DOI":"10.1016\/j.tcm.2019.09.005"},{"issue":"2","key":"zoi240973r21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"3","key":"zoi240973r22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.","volume":"20","author":"Randolph","year":"1998","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"zoi240973r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280443","article-title":"Cigarette smoking is associated with herpesviruses in persons with and without serious mental illness.","volume":"18","author":"Dickerson","year":"2023","journal-title":"PLoS One"},{"key":"zoi240973r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.113755","article-title":"Risk factors for natural cause mortality in a cohort of 1494 persons with serious mental illness.","volume":"298","author":"Dickerson","year":"2021","journal-title":"Psychiatry Res"},{"issue":"6","key":"zoi240973r25","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1111\/hesr.2018.53.issue-6","article-title":"Development and validation of a high-quality composite real-world mortality endpoint.","volume":"53","author":"Curtis","year":"2018","journal-title":"Health Serv Res"},{"issue":"7","key":"zoi240973r26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","article-title":"A primer and comparative review of major US mortality databases.","volume":"12","author":"Cowper","year":"2002","journal-title":"Ann Epidemiol"},{"issue":"5","key":"zoi240973r27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/acps.2018.137.issue-5","article-title":"Natural cause mortality in persons with serious mental illness.","volume":"137","author":"Dickerson","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"zoi240973r28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ageing\/afu188","article-title":"Cognitive impairment, all-cause and cause-specific mortality among non-demented older adults.","volume":"44","author":"Perna","year":"2015","journal-title":"Age Ageing"},{"issue":"1-3","key":"zoi240973r29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.schres.2015.09.009","article-title":"Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: a prospective 15-year study.","volume":"169","author":"Helldin","year":"2015","journal-title":"Schizophr Res"},{"key":"zoi240973r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.scog.2023.100284","article-title":"Neurocognitive function and mortality in patients with schizophrenia spectrum disorders.","volume":"33","author":"Mohn","year":"2023","journal-title":"Schizophr Res Cogn"},{"issue":"3","key":"zoi240973r31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cncr.v120.3","article-title":"Cancer care for individuals with schizophrenia.","volume":"120","author":"Irwin","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"zoi240973r32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1192\/bjp.bp.116.195776","article-title":"Cancer mortality in patients with schizophrenia: systematic review and meta-analysis.","volume":"211","author":"Zhuo","year":"2017","journal-title":"Br J Psychiatry"},{"issue":"1","key":"zoi240973r33","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.v4.1","article-title":"The somatic care situation of people with mental illness.","volume":"4","author":"Haussleiter","year":"2020","journal-title":"Health Sci Rep"},{"issue":"6","key":"zoi240973r34","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/eip.v15.6","article-title":"Health literacy of people living with mental illness or substance use disorders: a systematic review.","volume":"15","author":"Degan","year":"2021","journal-title":"Early Interv Psychiatry"},{"issue":"4","key":"zoi240973r35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/schbul\/sbab022","article-title":"A meta-analysis of cognitive remediation for schizophrenia: efficacy and the role of participant and treatment factors.","volume":"47","author":"Lejeune","year":"2021","journal-title":"Schizophr Bull"},{"issue":"11","key":"zoi240973r36","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2105\/AJPH.2009.180273","article-title":"Burden of mortality associated with autoimmune diseases among females in the United Kingdom.","volume":"100","author":"Thomas","year":"2010","journal-title":"Am J Public Health"},{"key":"zoi240973r37","doi-asserted-by":"publisher","journal-title":"Psychiatr Q","DOI":"10.1007\/s11126-018-9621-4"},{"issue":"1","key":"zoi240973r38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.schres.2015.11.010","article-title":"Mortality in schizophrenia and bipolar disorder: clinical and serological predictors.","volume":"170","author":"Dickerson","year":"2016","journal-title":"Schizophr Res"},{"issue":"4","key":"zoi240973r39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/aje\/kwt335","article-title":"The 2014 Surgeon General\u2019s report: commemorating the 50th anniversary of the 1964 report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking.","volume":"179","author":"Alberg","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi240973r40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/acp.2006.113.issue-4","article-title":"Obesity among individuals with serious mental illness.","volume":"113","author":"Dickerson","year":"2006","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"zoi240973r41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.genhosppsych.2015.03.004","article-title":"Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness.","volume":"37","author":"Janssen","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"zoi240973r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101429","article-title":"Excess mortality associated with elevated body weight in the USA by state and demographic subgroup: a modelling study.","volume":"48","author":"Ward","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"5","key":"zoi240973r43","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2022-100819","article-title":"Body mass index and mortality in patients with schizophrenia spectrum disorders: a cohort study in a South London catchment area.","volume":"35","author":"Chen","year":"2022","journal-title":"Gen Psychiatr"},{"issue":"5","key":"zoi240973r44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/15412555.2010.510160","article-title":"Mortality in COPD: causes, risk factors, and prevention.","volume":"7","author":"Berry","year":"2010","journal-title":"COPD"},{"issue":"28","key":"zoi240973r45","doi-asserted-by":"publisher","first-page":"16273","DOI":"10.1073\/pnas.1918455117","article-title":"Predicting mortality from 57 economic, behavioral, social, and psychological factors.","volume":"117","author":"Puterman","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"zoi240973r46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/spco.2012.6.issue-12","article-title":"Divorce and death: a case study for health psychology.","volume":"6","author":"Sbarra","year":"2012","journal-title":"Soc Personal Psychol Compass"},{"issue":"7","key":"zoi240973r47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000316","article-title":"Social relationships and mortality risk: a meta-analytic review.","volume":"7","author":"Holt-Lunstad","year":"2010","journal-title":"PLoS Med"},{"issue":"7","key":"zoi240973r48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000507044","article-title":"Time trends in the use of coronary procedures, guideline-based therapy, and all-cause mortality following the acute coronary syndrome in patients with schizophrenia.","volume":"145","author":"Attar","year":"2020","journal-title":"Cardiology"},{"key":"zoi240973r17","volume-title":"Structured Clinical Interview for DSM-IV Disorders, Non-Patient Edition","author":"First","year":"1998"},{"key":"zoi240973r18","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","edition":"4th ed"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2823323\/dickerson_2024_oi_240973_1724971270.15176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:01:20Z","timestamp":1725966080000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2823323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.32401","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}